ACET Q4 2018 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$431M+0.0% YoY

Gross Profit

-$749M174.0% margin

Operating Income

-$89M20.7% margin

Net Income

-$68M15.8% margin

EPS (Diluted)

$-47.04

QoQ Revenue Growth

-Infinity%

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$56M

Stock-Based Comp.

-$2M

Balance Sheet

Total Assets

$110M

Total Liabilities

$6M

Stockholders' Equity

$104M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$431M	-$431M	+0.0%
Gross Profit	-$749M	-$749M	+0.0%
Operating Income	-$89M	-$68M	-30.6%
Net Income	-$68M	-$64M	-6.0%

Revenue Segments

Human Health

$85M52%

Pharmaceutical Ingredients

$42M26%

Performance Chemicals

$37M22%